TERN vs VFC · $6.12B cap vs P/E 26, rev $9.50B
Terns Pharmaceuticals Inc (TERN) versus VF Corporation (VFC) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported VFC revenue for 2025-03-29 was $9.50B. Net income was -$189.7M. Revenue was down 4.1% from 2024-03-30 to 2025-03-29. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
TERN currently screens at market cap $6.12B. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Not investment advice. Open the TERN and VFC stock pages for the full models.
Not investment advice.